|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-10-1
|
|
pubmed:abstractText |
Serotonin activity has been shown to be increased in the basal ganglia of patients with progressive supranuclear palsy (PSP), and may be responsible for its extrapyramidal features that do not respond to 1-dopa.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0009-918X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
42-4
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12355852-Aged,
pubmed-meshheading:12355852-Aged, 80 and over,
pubmed-meshheading:12355852-Female,
pubmed-meshheading:12355852-Humans,
pubmed-meshheading:12355852-Isoindoles,
pubmed-meshheading:12355852-Male,
pubmed-meshheading:12355852-Piperazines,
pubmed-meshheading:12355852-Pyrimidines,
pubmed-meshheading:12355852-Serotonin Receptor Agonists,
pubmed-meshheading:12355852-Supranuclear Palsy, Progressive
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
[Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy].
|
|
pubmed:affiliation |
Department of Medicine (Neurology), Fukuoka University School of Medicine.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Evaluation Studies
|
